1 | Sphingosine-1-Phosphate Receptor 1 Activity Promotes Tumor Growth by Amplifying VEGF-VEGFR2 Angiogenic Signaling. (Balaji Ragunathrao VA, Anwar M, Akhter MZ, Chavez A, Mao Y, Natarajan V, Lakshmikanthan S, Chrzanowska-Wodnicka M, Dudek AZ, Claesson-Welsh L, Kitajewski JK, Wary KK, Malik AB, Mehta D) Cell Rep 2019 Dec 10;29(11):3472-3487.e4 42 Citations |
1 | ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells. (Shimizu A, Mammoto A, Italiano JE Jr, Pravda E, Dudley AC, Ingber DE, Klagsbrun M) J Biol Chem 2008 Oct 03;283(40):27230-8 87 Citations |
1 | Emerging safety issues with imatinib and other Abl tyrosine kinase inhibitors. (Atallah E, Kantarjian H, Cortes J) Clin Lymphoma Myeloma 2007 Mar;7 Suppl 3:S105-12 26 Citations |
1 | Autoantibodies to Abl and Bcr proteins. (Talpaz M, Qiu X, Cheng K, Cortes JE, Kantarjian H, Kurzrock R) Leukemia 2000 Sep;14(9):1661-6 3 Citations |
1 | Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. (Chen G, Yuan SS, Liu W, Xu Y, Trujillo K, Song B, Cong F, Goff SP, Wu Y, Arlinghaus R, Baltimore D, Gasser PJ, Park MS, Sung P, Lee EY) J Biol Chem 1999 Apr 30;274(18):12748-52 241 Citations |
1 | Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. (Wetzler M, Talpaz M, Van Etten RA, Hirsh-Ginsberg C, Beran M, Kurzrock R) J Clin Invest 1993 Oct;92(4):1925-39 178 Citations |
1 | Fusion of the bcr and the c-abl genes in Ph'-positive acute lymphocytic leukemia with no rearrangement in the breakpoint cluster region. (ar-Rushdi A, Negrini M, Kurzrock R, Huebner K, Croce CM) Oncogene 1988 Apr;2(4):353-7 17 Citations |